Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideki Ito

Showing results (21-30 of 254) with videos related to

Pageof 26
Sort By:
Zoological Science|November 12, 2002
Anatomy of the planarian Dugesia japonica I. The muscular system revealed by antisera against myosin heavy chainsHidefumi Orii, Hideki Ito, Kenji Watanabe
Platelets|September 17, 2004
Cilostazol inhibits platelet-leukocyte interaction by suppression of platelet activationHideki Ito, Goro Miyakoda, Toyoki Mori
Thrombosis and Haemostasis|March 18, 2006
Genetic strain differences in platelet aggregation of laboratory miceToshiki Sudo, Hideki Ito, Yukio Kimura
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 17, 2013
[Emergency medical service system for elderly patients]Hideki Ito, Shu Kobayashi, Yusuke Tsuboko
Chemical & Pharmaceutical Bulletin|June 13, 2012
Effect of the moisture content in aerosol on the spray performance of Stmerin ® D hydrofluoroalkane preparations (2)Saburo Murata, Takashi Izumi, Hideki Ito
Pharmaceutical Development and Technology|April 24, 2012
Reformulation of Stmerin(®) D CFC formulation using HFA propellantsSaburo Murata, Takashi Izumi, Hideki Ito
Neuropharmacology|November 11, 2017
Long-term cilostazol administration prevents age-related decline of hippocampus-dependent memory in miceShuichi Yanai, Hideki Ito, Shogo Endo
Platelets|November 7, 2003
Phosphorylation of the vasodilator-stimulated phosphoprotein (VASP) by the anti-platelet drug, cilostazol, in plateletsToshiki Sudo, Hideki Ito, Yukio Kimura
Heart, Lung & Circulation|August 1, 2020
Exclusion Technique for Entire Shaggy Aorta Followed by One-Stage Repair of the Aortic Arch and Descending AortaMasato Mutsuga, Hideki Ito, Akihiko Usui
Geriatrics & Gerontology International|April 19, 2021
Which is a better predictor for adverse events in older adults with diabetes, frailty or higher-level functional incapacity?Takuya Omura, Hideki Ito, Atsushi Araki
Pageof 26

Showing results (21-30 of 254) with videos related to

Sort By:
Pageof 26
Zoological Science|November 12, 2002
Anatomy of the planarian Dugesia japonica I. The muscular system revealed by antisera against myosin heavy chainsHidefumi Orii, Hideki Ito, Kenji Watanabe
Platelets|September 17, 2004
Cilostazol inhibits platelet-leukocyte interaction by suppression of platelet activationHideki Ito, Goro Miyakoda, Toyoki Mori
Thrombosis and Haemostasis|March 18, 2006
Genetic strain differences in platelet aggregation of laboratory miceToshiki Sudo, Hideki Ito, Yukio Kimura
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 17, 2013
[Emergency medical service system for elderly patients]Hideki Ito, Shu Kobayashi, Yusuke Tsuboko
Chemical & Pharmaceutical Bulletin|June 13, 2012
Effect of the moisture content in aerosol on the spray performance of Stmerin ® D hydrofluoroalkane preparations (2)Saburo Murata, Takashi Izumi, Hideki Ito
Pharmaceutical Development and Technology|April 24, 2012
Reformulation of Stmerin(®) D CFC formulation using HFA propellantsSaburo Murata, Takashi Izumi, Hideki Ito
Neuropharmacology|November 11, 2017
Long-term cilostazol administration prevents age-related decline of hippocampus-dependent memory in miceShuichi Yanai, Hideki Ito, Shogo Endo
Platelets|November 7, 2003
Phosphorylation of the vasodilator-stimulated phosphoprotein (VASP) by the anti-platelet drug, cilostazol, in plateletsToshiki Sudo, Hideki Ito, Yukio Kimura
Heart, Lung & Circulation|August 1, 2020
Exclusion Technique for Entire Shaggy Aorta Followed by One-Stage Repair of the Aortic Arch and Descending AortaMasato Mutsuga, Hideki Ito, Akihiko Usui
Geriatrics & Gerontology International|April 19, 2021
Which is a better predictor for adverse events in older adults with diabetes, frailty or higher-level functional incapacity?Takuya Omura, Hideki Ito, Atsushi Araki
Pageof 26